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A hallmark of Penn Vet, collaboration is a daily exercise 
for researchers, students, clinicians and colleagues 
You can’t whistle a symphony, a wise man 
once said. It takes an entire orchestra to play 
it. At Penn Vet, the ability to collaborate 
with others has allowed researchers to create 
some beautiful music, not to mention elegant 
science, together with colleagues, researchers 
from around the world, industry and even 
students from other academic institutions. 
Collaboration can yield valuable results, as 
these examples illustrate. 
Combating Cachexia in Cats 
Kendra K. Bence, PhD and Erika L. Krick, VMD joke that 
they met “speed dating.” That’s what organizers called the 
ice-breaking exercise at an annual faculty retreat that threw 
together staffers with similar interests who otherwise might 
never talk to one another. That day, Drs. Bence and Krick 
found themselves at the same table; today, they’re at the 
same bench. The two are collaborating on a translational 
study looking at the similarities in cats and humans of 
cachexia, a metabolic wasting syndrome that occurs in cancer 
— often GI cancers — and other diseases. 
It’s the perfect melding of professional interests. Dr. Bence 
is an assistant professor in the animal biology department 
where she studies the cellular mechanism of feeding and 
obesity in mice that serve as stand-ins for the humans caught 
in the double epidemic of obesity and diabetes. Dr. Krick 
is a clinical veterinary oncologist with a special interest 
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Drs. Kendra Bence (left) and Erika Krick 
Penn Vet student Nadia Azam observes.
in studying and treating cats with lymphoma and cachexia. 
They’ve been joined by second-year Penn Vet student 
Nadia Azam (V’14) who was awarded a Merial scholarship 
to participate in the research. The Veterinary Clinical 
Investigation Center (VCIC) is also involved.
Patients with cachexia — both feline and human — 
experience a loss of appetite, weight and muscle mass that isn’t 
remedied by supplements or extra calories. They also respond 
poorly to cancer treatment. 
“Cats who are skinny and not feeling well from their cancer 
may not tolerate standard chemotherapy doses. Sometimes 
they are given lower doses of chemotherapy, which could 
decrease the chance that they will respond,” said Dr. Krick, 
who is also collaborating with researchers at Texas A&M 
University on a study of feline lymphoma. “Also, we have 
found that cats that lose weight during treatment have a 
significantly shorter survival time than cats that don’t lose 
weight.”  
In fact, she says, as many as 30 percent of people with 
cancer cachexia die from the condition.
The villain? Likely pro-inflammatory cytokines, elevated 
in cancer cachexia patients, that speed muscle loss, decrease 
intestinal motility and gastric emptying leading to early satiety, 
and alter production of hypothalamic neuropeptides that 
govern appetite.
The first aim of the study is to discover if cachectic cats 
with cancer have different inflammatory markers than healthy 
cats and those with cancer but who aren’t cachectic. The 
researchers are also looking at the gene expression of appetite 
controlling peptides in the brain, specifically the orexigenic 
neuropeptides NPY and AGRP that stimulate eating, and 
the anorexic neuropeptides POMC and CART that suppress 
the desire to feed. Preliminary results have been partially 
unexpected, but intriguing. 
“Surprisingly we found no change in NPY and AGRP with 
fasting, but we did see the expected suppression of POMC 
and CART,” said Dr. Bence. “As we go on, we may need 
to expand the number of neuropeptides we examine. It may 
have been that the fast we did [overnight] with the cats wasn’t 
long enough to see changes in orexigenic peptides. Or it may 
be that cats utilize alternate neuropeptides in their response to 
feeding and hunger compared to other species.”
Ultimately, the researchers would like to discover a marker 
that would alert a clinician — like Dr. Krick — that an animal 
is more likely to develop cachexia. 
“Then,” said Dr. Bence, “it’s not out of the question 
that we could design new treatment strategies for our feline 
patients that can be translated to humans.” 
Sharing a Living Laboratory
Sue McDonnell, PhD, head of the Havemeyer Equine 
Behavior Research Program at Penn Vet’s New Bolton 
Center, has learned that when you build a better herd, 
everyone will beat a path to your pasture.
The herd, in this case, is made up of 95 semi-feral ponies 
that roam 35 acres of lush grassland at the New Bolton Center 
in Kennett Square. Since the herd was started in 1994 (with 
13 mares and 13 stallions from domestic stock), it has become 
a living laboratory, drawing not only equine researchers and 
clinicians from around the world, but high school students, 
university undergrads and graduate students, and vet tech and 
nursing students who might never have an opportunity to 
observe horses in the wild.
Or, in this case, the semi-wild. Penn Vet’s ponies forage, 
mate when they want to, get plenty of exercise because 
they’re never indoors, but, unlike wild horses, are acclimated 
to humans who provide some minimal veterinary care — and 
come to watch. (With a housing development abutting one 
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Dr. Krick examines a patient with cachexia.
Dr. McDonnell’s semi-feral pony herd serves as a living laboratory for 
Penn Vet students and researchers as well as for area universities.
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pasture, they likely also get supplemental treats from young 
neighbors despite a large “don’t feed the ponies” warning on 
the fence.)
“It’s not exactly like going to see wild horses. They are 
contained, but that’s the beauty of it,” said Dr. McDonnell, 
who has been at Penn Vet since 1981. “We’ve seen them 
every day since 1994, and because their wandering is limited 
to the pasture enclosure we can observe the whole herd so 
we know a lot more about their natural social organization 
than we would if they were out west where the terrain is so 
tough and the forage is so sparse that the horses are spread out. 
There, the best you can do is stay with one family at a time, 
so you are unable to readily understand the social interactions 
among families.”
But it’s more than just convenience that lures researchers 
and students (from places like the University of Delaware, 
Delaware Valley College of Science and Agriculture, Penn 
State, Cazenovia College and Penn’s own psychology 
department) to this classroom on the hoof. It’s also what’s 
been — and can be — learned there. 
“Once you get students attuned to natural horse behavior, 
they see that most health problems in horses have resulted 
from how we manage them,” said Dr. McDonnell. 
The Penn Vet herd doesn’t experience the same health 
problems as domestic equines. There’s no colic, no laminitis 
and no sexual dysfunction, the bane of many breeders who 
also come to consult with Dr. McDonnell.
Since the herd has become a lure for students, said Dr. 
McDonnell, the center has created short courses specifically 
for them that their own institutions have neither the resources 
nor faculty to provide. As a bonus, she says, “these courses 
generate funds that help to support the herd.”
There have been some other unanticipated benefits of what 
could be called Penn Vet’s open pasture gate policy. 
 Ensuring a Safer Egg
Penn Vet researcher leads charge in 
developing safe-egg testing kit for FDA
In August 2010, an outbreak of Salmonella Enteritidis (SE) was responsible for illness in almost 2,000 people in at least 25 states. More than 550 million eggs were 
recalled from the market. While methods have been in 
place to test for the presence of SE in eggs, the traditional 
methodology is time consuming, requiring up to 10 days to 
determine the presence or absence of SE in egg samples.
Recognizing that this timeframe wasn’t acceptable, the 
microbiology laboratory at Penn Vet’s New Bolton Center 
chain reaction (PCR) test developed at Penn Vet allows 
quick determination of the presence or absence of SE in 
egg samples, and provides accurate results in approximately 
27 hours – a tenfold reduction in waiting time for results. 
This methodology came in handy for the Federal Egg 
Safety Program, which requires all large-scale producers in 
the US to test for SE before products reach consumers.
As a result, the Salmonella Enteritidis Detection Kit was 
developed by Shelley Rankin, PhD, associate professor of 
microbiology at Penn Vet and chief of NBC’s microbiology, 
in collaboration with The Life Technologies Corporation, 
which allows producers to quickly test their eggs for SE. 
FDA-approved for use in the Federal Egg Safety Program 
in early 2011, the kit was validated by Dr. Rankin’s lab.
“Penn Vet has been collaborating with the Commonwealth 
of Pennsylvania to ensure food safety for decades,” said 
Joan C. Hendricks, VMD, PhD, the Gilbert S. Kahn Dean 
of Penn Vet. “The adoption of our egg-testing protocols 
by the FDA illustrates our researchers’ success in their 
play in ensuring public health and food safety. I am 
thrilled that Penn Vet is continuing to lead the way in 
setting the standard in food safety and public health.”
“The FDA equivalence determination for this test marks 
a milestone for the egg industry in this country,” said Dr. 
nation to initiate a voluntary egg quality assurance program 
and the Pennsylvania Animal Diagnostic Laboratory System 
It’s very exciting that the FDA has adopted this test for 
the Federal Egg Safety Program. This action demonstrates 
their commitment to delivering the safest quality food to 
the consumer and I’m proud to be a part of that trend.”
Penn Vet has been active in the development and 
implementation of the state’s PEQAP (Pennsylvania Egg 
Quality Assurance Program), and much of what has been 
learned and shared by PEQAP forms the basis for the 
national Egg Safety Program. Dr. Rankin has more than 20 
years experience in the detection and characterization 
of Salmonella from human and animal sources.
—Sally Silverman
Mare and foal behavior is just one of the many interactions Dr. 
McDonnell and her team study in the semi-feral pony herd.
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“We get the opportunity to meet some real star students, 
some of whom are inspired to study vet medicine and apply to 
Penn,” said Dr. McDonnell. 
And in one case, a student from the University of Delaware 
launched an ongoing independent study based on a Penn Vet 
project using recorded stallion vocalizations and stallion scent 
for estrus detection in mares. It’s allowing Dr. McDonnell and 
her colleagues to find a solution for a problem that faces small 
farmers but which can’t be tested in the Penn Vet research and 
teaching herd.
“Our mares are exposed to stallions on the property, but 
what if you’re out in the middle of nowhere with no stallions 
around,” she said.  “At the University of Delaware, they had 
only a few mares at the time and no stallion. This project by 
one of our student visitors gives us the opportunity to do a 
real-world test of the problem.”
Predicting Epileptic Seizures 
for Novel Treatment Options
When it comes to epilepsy, dogs and humans have much in 
common. Their rate of idiopathic epilepsy is about the 
same. And their treatment options are similar — and equally 
inadequate. 
“The problem for people with epilepsy is they may have 
a seizure once or twice a year, but they’re on medication all 
year,” said Charles Vite, DVM, PhD, assistant professor of 
neurology and neurosurgery in the Department of Clinical 
Studies at Penn Vet. “These drugs are not benign. They can 
have side effects, including cognitive dysfunction, depression 
and liver failure.” 
And for over 30 percent of people — and dogs — the 
drugs don’t adequately control seizures.
But here’s where dogs and people differ. Epilepsy doesn’t 
usually dramatically circumscribe a dog’s life. It does for 
humans. 
“People with epilepsy can’t drive, they have a hard time 
holding down certain jobs and they take a lot of drugs,” 
said Dr. Vite. “But what if they could predict when they 
were going to have a seizure, or when a seizure was likely to 
happen? If they had a box that would flash blue when they 
were okay they could say, ‘Great, it’s blue today, I can drive,’ 
that would be a wonderful thing.”
Through a collaboration involving Penn Vet, NeuroVista, 
a premier medical technology developer with Penn Vet 
connections, and researchers at the Mayo Clinic, University 
of Minnesota and the University of California at Davis, that 
“wonderful thing” is one step closer to reality. The team is 
expecting to receive a translational research grant this fall and 
are awaiting a funding decision. 
Dr. Vite, Penn neurologists Kathryn A. Davis, MD, 
and Brian Litt, MD, along with the VCIC, joined Mayo, 
University of Minnesota and UC-Davis researchers to test an 
implantable device in dogs that may predict a “perfect storm” 
in the brain’s electrical system that signals a seizure — before 
it even happens. The device was developed by NeuroVista, a 
Seattle firm specializing in implantable neurological products. 
Dr. Litt is a scientific advisor to the company; its vice 
president of clinical research is Penn Vet alum and Medical 
Scientist Training Program graduate W. Douglas Sheffield, 
VMD, PhD.
The device includes implantable (subdural) strip monitoring 
electrodes and a sub-dermal telemetry unit which wirelessly 
transmits EEG signals to an external personal advisory device 
(PAD), much like a pager, with colored lights — including 
the blue one Dr. Vite was talking about — as well as vibrating 
and audible alarms. The data is collected on ordinary flash 
memory cards and can be downloaded to a computer for 
storage and analysis.
The results of the first test, in six dogs with naturally 
occurring epilepsy, was published this year in the journal 
Epilepsy Research. Analyzing more than 11,000 continuous 
hours of iEEG data and clinical observation, the researchers 
found that canine epilepsy is “a promising model” for human 
epilepsy for testing implantable devices: When having seizures, 
dogs and humans share similar patterns in brain activity and 
observable symptoms.
Though far from market-ready, the device has the potential 
to exert profound effects on epilepsy research and care. 
“If we are able to give people with epilepsy or a dog owner 
one-to-two hours notice before a seizure occurs, this will repre-
sent a massive change in how we treat epilepsy,” said Dr. Vite. 
Instead of taking drugs every day, a person with epilepsy 
may be able to take a fast-acting antiepileptic drug only on 
days when a seizure warning is sounded. 
While the long-range goal of the study is to find better 
ways to treat human patients, Dr. Vite said, “As I remind 
everyone, I’m a vet. I’m here to help dogs and cats.” In fact, 
he says, he has about 600 active epilepsy cases and this month 
[October] he launched a weekly clinic strictly for epileptic 
animals. 
Fortunately, whatever the research in dogs uncovers to help 
humans will also help animals. 
“It could give us more options to offer when we get calls 
from owners and breeders asking if there’s anything new for 
epilepsy,” said Dr. Vite. 
Drs. Brian Litt and Charles Vite are working together to help humans and animals 
with epilepsy.
